Citations

Mayo Clinic

Showing 10 of 108602 citations.

Both DNA Polymerases δ and ε Contact Active and Stalled Replication Forks Differently
Yu, Chuanhe , Gan, Haiyun , Zhang, Zhiguo , Zhang, Zhiguo , Yu, Chuanhe

Molecular and Cellular Biology | August 7, 2017 | Volume: 37 | Issue: 21 | Pages: No page available

10.1128/mcb.00190-17 | PMID 28784720 Get It

When Lightning Strikes
Cooper, Leslie T. , Cooper, Leslie T

Circulation | August 7, 2017 | Volume: 136 | Issue: 6 | Pages: 546-548

10.1161/circulationaha.117.029340 | PMID 28784824 Get It

Total Artificial Heart: A Retrospective Multiple-Case Analysis of Occupational Therapy in a Quaternary Hospital
Oldenburg, Hannah , Bergstrom, Jennifer, Christensen, Gina, Polley, Caitlin A., Privette, R. Malcolm, Maureen, Musselmann, Pyffereon, Mary, Brannon, Charles

American Journal of Occupational Therapy | August 7, 2017 | Volume: 71 | Issue: 1_suppl | Pages: No page available

10.5014/ajot.2017.71s1-po4068 Get It

Date Presented 3/31/2017 A retrospective multicase study of functional outcomes was done with patients with an implanted total artificial heart. Results show improved function with occupational therapy provided postoperatively. Knowledge and evidence can be used to develop and implement interventions for this population. Primary Author and Speaker: Hannah Oldenburg Additional Authors and Speakers: Jennifer Bergstrom, Gina Christensen Contributing Authors: Caitlin Polley, Randi Privette, Maureen Musselmann, Mary Pyffereon, Charles Brannon
Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort
Albert, Marilyn S. , Alonso, Álvaro , Coker, Laura H., Davis, Sonia M., Mosley, Thomas H., Sharrett, A. Richey , Windham, B. Gwen , Wruck, Lisa , Thomas, Sonia , Alonso, Alvaro , Gottesman, Rebecca F. , Coresh, Josef , Deal, Jennifer A. , McKhann, Guy M. , Mosley, Thomas H., Schneider, Andrea L.C. , Knopman, David S. , Wruck, Lisa M , Thomas, Sonia M

JAMA Neurology | August 7, 2017 | Volume: 74 | Issue: 10 | Pages: 1246

10.1001/jamaneurol.2017.1658 | PMID 28783817 Get It

Big Data and Genome Editing Technology: A New Paradigm of Cardiovascular Genomics
Krittanawong, Chayakrit , Sun, Tao , Herzog, Eyal

Current Cardiology Reviews | August 7, 2017 | Volume: 13 | Issue: 4 | Pages: No page available

10.2174/1573403x13666170804152432 | PMID 28782493 Get It

Pneumonia and atrial flutter in a 71- year-old-man
Konik, Ewa, Sinak, Lawrence J., Wiley, Brandon M. , Sinak, Lawrence, Wiley, Brandon

BMJ Case Reports | August 7, 2017 | Volume: 2017 | Issue: No issue available | Pages: bcr-2017-220691

10.1136/bcr-2017-220691 | PMID 28784891 Get It

Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics
Waldman, Scott A. , Waldman, Scott A , Terzic, André

Clinical Pharmacology & Therapeutics | August 7, 2017 | Volume: 102 | Issue: 3 | Pages: 373-377

10.1002/cpt.763 | PMID 28782825 Get It

Clinical Pharmacology & Therapeutics (CPT) is an established voice of the discipline, a trusted source of new knowledge showcasing discovery, translation, and application of novel therapeutic paradigms to advance the management of patients and populations. Identifying, evaluating, prioritizing, and disseminating the best science along the discovery–development–regulatory–utilization continuum are responsibilities shared through peer review. To enhance the uniformity of this essential component of quality assurance and innovation, and maximize the value of the journal and its contents to authors, reviewers, and the readership, we review key concepts concerning peer review as it specifically relates to CPT.
Undetectable negative tissue transglutaminase IgA antibodies predict mucosal healing in treated coeliac disease patients
Larson, Joseph J. , Snyder, Melissa R. , Wu, T. T. , Murray, Joseph A. , Murray, J A , Fang, Hong , King, Katherine S. , Gandhi, Manish J.

Alimentary Pharmacology & Therapeutics | August 7, 2017 | Volume: 46 | Issue: 7 | Pages: 681-687

10.1111/apt.14250 | PMID 28782118 Get It

SummaryBackgroundTissue transglutaminase (tTG) immunoglobulin A (IgA) testing is a sensitive adjunct to the diagnosis of coeliac disease. The threshold for positivity was developed for diagnosis, with negative results reported as below the reference value (<4 U/mL).AimTo investigate if an undetectable (tTG IgA<1.2 U/mL) is more predictive of healing compared to patients with negative but detectable serology (1.2‐3.9 U/mL).MethodsWe performed a retrospective study of 402 treated coeliac disease patients seen at the Mayo Clinic with negative tTG IgA values drawn within 1 month of duodenal biopsy between January 2009 and December 2015. The Corazza‐Villanacci score was used to assess mucosal healing. The presence of gastrointestinal symptoms was also collected. Logistic regression was used to assess the relationship of clinical variables with a normal biopsy.ResultsPatients with undetectable titres more frequently had normal duodenal histology compared to patients with detectable tTG IgA levels (117/240 vs. 53/162; OR=1.96; 1.292, 2.961). Asymptomatic patients more frequently had normal duodenum as compared to symptomatic patients (88/163 vs. 82/239; OR=2.25; CI: 1.494, 3.377). Patients with undetectable serology and on a gluten‐free diet for ≥2 years were more likely to have no villous atrophy compared to patients with detectable serology (148/192 vs. 55/88; OR=2.02; CI: 1.17, 3.49).ConclusionIn subjects recovering from coeliac disease with negative tTG IgA serology, an undetectable titre is associated with normal histology on follow‐up biopsy.
Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis
Tefferi, Ayalew , Mudireddy, Mythri , Gangat, Naseema , Hanson, Curtis A. , Ketterling, Rhett P. , Pardanani, Animesh , Nagorney, David M. , Ketterling, Rhett P

American Journal of Hematology | August 7, 2017 | Volume: 92 | Issue: 11 | Pages: 1187-1192

10.1002/ajh.24881 | PMID 28782256 Get It

AbstractPalliative treatment in myelofibrosis (MF) includes transfusion support, JAK2 inhibitors, involved field radiotherapy and splenectomy. To assist in selecting patients who are likely to benefit from splenectomy, we looked into risk factors for postsplenectomy survival, in 120 consecutive cases (median age 66 years); at the time of splenectomy, 61% displayed red cell transfusion need, 49% platelet count <100 × 10(9)/L, 25% leukocyte count >25 × 10(9)/L, 60% constitutional symptoms and 13% circulating blasts ≥5%; dynamic international prognostic scoring system risk categories were 21% high, 55% intermediate‐2, 21% intermediate‐1 and 3% low. Among informative cases, karyotype was abnormal in 60% and driver mutational status was JAK2 75%, CALR 15%, MPL 4% and triple‐negative 6%. At median follow‐up of 1.3 years, from time of splenectomy, 95 (79%) deaths and 30 (25%) leukemic transformations were recorded. Median postsplenectomy survival was 1.5 years; in multivariable analysis, survival was adversely affected by age >65 years, transfusion need, leukocyte count >25 × 10(9)/L and circulating blasts ≥5%; these variables were subsequently used to devise an HR‐weighted scoring system with high (3‐4 risk factors), intermediate (2 risk factors) and low (0‐1 risk factors) risk categories; the corresponding postsplenectomy median survivals were 0.3 (HR 5.9, 95% CI 3.2‐11.0), 1.3 (HR 2.9, 95% CI 1.8‐4.6) and 2.9 years. Postsplenectomy survival was not affected by driver mutational status or occurrence of leukemic transformation. Leukemia‐free survival was predicted by very high risk karyotype. The observations from the current study might help identify appropriate candidates for splenectomy in MF.
Lateral Meniscus Allograft Transplantation: The Bone Plug Technique
Johnson, Nick R., Levy, Bruce A. , Krych, Aaron J. , Woodmass, Jarret M, Krych, Aaron J , Woodmass, Jarret Murray , Stuart, Michael J.

Arthroscopy Techniques | August 7, 2017 | Volume: 6 | Issue: 4 | Pages: No page available

10.1016/j.eats.2017.04.016 | PMID 29354420 Get It

Abstract Lateral meniscus tears are commonly encountered by orthopaedic surgeons. Despite efforts to repair and preserve the meniscus, meniscectomy is occasionally required to treat irreparable tears. The resulting lateral meniscus deficiency leads to increased tibiofemoral contact pressures and ultimately early osteoarthritic changes in the knee. Lateral meniscal allograft transplant (LMAT) has been proposed as a way to restore the lateral meniscus–deficient knee to its native form. Although several techniques for LMAT have been proposed, osseous fixation has demonstrated increased stability, improved outcomes, and improved long‐term survival. This article presents a technique for LMAT using bone plugs and standard arthroscopic portals. Technique Video video See video under supplementary data.